You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

429 Results
Regimen
Cancer Type:
Hematologic, 
Myeloproliferative Neoplasms (MPNs)
Intent: Palliative
Funding:
Exceptional Access Program
    fedratinib - For the treatment of splenomegaly and/or disease related symptoms of myelofibrosis according to clinical criteria
Jan 2025
The cervical screening test checks for types of human papillomavirus (HPV) that can sometimes cause cervical cancer. It also checks for cell changes...
The following information answers many of the questions primary care physicians commonly ask about the Screening Activity Report and the included...
A variety of screening tools and resources are available to support the screening activities of primary care providers, nurses and specialists.
Drug
Other Name(s): Sylvant®
Mar 2025
Regimen
Cancer Type:
Hematologic, 
Rare Diseases
Intent: Palliative
Funding:
New Drug Funding Program
    Siltuximab - Multicentric Castleman’s Disease (MCD)
Mar 2025
Les programmes cliniques d’Action Cancer Ontario sont mis en œuvre en collaboration avec les cliniciens des Programmes régionaux de cancérologie en...
A wide range of cancer screening, diagnostic and treatment services is available at cancer centres, hospitals and clinics throughout Ontario. Some of...
Le dépistage du cancer du poumon dans le cadre du Programme ontarien de dépistage du cancer du poumon est offert aux personnes admissibles dans un...
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®
Dec 1969

Pages